FREE Case Evaluation: 1-888-887-3117

Contact

Is There a Hair Relaxer Class Action Lawsuit in 2025? An Update

Is There a Hair Relaxer Class Action Lawsuit in 2025? An Update

Understanding the Wave of Hair Relaxer Litigation

Lawsuits against hair relaxers have surged since a landmark 2022 study, with thousands of women alleging that chemical straightening products caused them to develop serious health conditions, particularly uterine and ovarian cancer. These cases have been consolidated into a federal multidistrict litigation (MDL 3060) in Illinois, with over 10,000 pending claims as of early 2026.

Quick Facts About Hair Relaxer Lawsuits:

  • What they allege: Chemical hair relaxers contain harmful ingredients like phthalates and formaldehyde that increase cancer risk.
  • Who can file: Women diagnosed with uterine, ovarian, or endometrial cancer after regular relaxer use.
  • Current status: Cases are consolidated in a federal MDL, with initial bellwether trials underway in 2025-2026.
  • Brands involved: L'Oréal (Dark & Lovely), Revlon, Namaste (ORS), Strength of Nature (Motions, Just for Me).
  • Settlements: None yet, but cases are progressing through findy and initial trials.

The catalyst for this litigation was a 2022 National Institutes of Health study that found women who frequently used chemical hair straighteners were more than twice as likely to develop uterine cancer compared to those who never used these products. The study revealed that 4.05% of frequent users would develop uterine cancer by age 70, versus just 1.64% of non-users.

"I wanted the bone straight hair that flowed flawlessly on the Black women I saw on television," recalled plaintiff JoAnna Zackery, who used relaxers for over 30 years before her uterine cancer diagnosis. Her story echoes thousands of others seeking legal recourse.

The litigation centers on allegations that cosmetic companies knew or should have known about the cancer risks posed by endocrine-disrupting chemicals in their products but failed to warn consumers. Black women, who comprise the majority of plaintiffs, were specifically targeted by marketing campaigns for decades.

As Tim Burd, founder of Justice Hero and Mass Tort Strategies, I've spent years helping connect individuals harmed by defective products with experienced legal representation, including those affected by lawsuits against hair relaxers. My mission is to break down complex legal processes into clear, actionable guidance.

Infographic showing timeline from 2022 NIH study publication to formation of MDL 3060, including key milestones: October 2022 - NIH study published linking relaxers to cancer, November 2022 - First lawsuits filed, February 2023 - MDL 3060 established in Northern District of Illinois, 2024 - Discovery phase and motions to dismiss denied, 2025-2026 - Bellwether trials begin, 10,000+ pending cases - lawsuit against hair relaxers infographic infographic-line-5-steps-blues-accent_colors

Simple guide to lawsuit against hair relaxers:

The Science Behind the Lawsuits: Linking Hair Relaxers to Cancer

At the heart of the lawsuit against hair relaxers lies compelling scientific evidence suggesting a link between these hair-straightening products and serious health issues. For decades, many used chemical relaxers, often unaware of the potential dangers within their ingredients. We at Justice Hero believe in empowering you with this crucial knowledge.

diagram showing the human endocrine system - lawsuit against hair relaxers

What Health Problems Are Linked to Hair Relaxers?

The primary health concerns driving the lawsuit against hair relaxers are various cancers and reproductive health problems. Studies have highlighted increased risks for:

  • Uterine Cancer: This is the most cited concern. Research indicates a significantly higher risk for frequent users of chemical relaxers. Uterine cancer includes endometrial cancer, which is the most common type. While the overall 5-year survival rate for uterine cancer is 81%, incidence has been rising, especially among Black women. Scientific research on uterine cancer shows endometrial cancer is more common than the rarer, more aggressive uterine sarcoma.
  • Ovarian Cancer: Some studies found an liftd risk of ovarian cancer among frequent relaxer users. This cancer is particularly dangerous due to its often late diagnosis.
  • Breast Cancer: A 2019 NIH study suggested a 30% higher risk of breast cancer in women who used chemical hair relaxers every five to eight weeks. A 2021 study further linked continuous use to breast cancer due to endocrine-disrupting chemicals.
  • Uterine Fibroids: A potential link has been found between hair relaxers and uterine fibroids, particularly in African American women. These benign growths can cause significant pain and may require a hysterectomy.

What Harmful Chemicals Are Found in These Products?

The alleged culprits are a cocktail of chemicals, many of which are endocrine disruptors (EDCs) that interfere with the body's hormonal system. Key chemicals identified in the lawsuit against hair relaxers include:

  • Phthalates: Often hidden in "fragrance," phthalates like Di(2-ethylhexyl)phthalate (DEHP) are known to cause cancer and birth defects in lab animals. They can mimic estrogen, potentially increasing the risk of hormone-sensitive cancers.
  • Formaldehyde: A known human carcinogen, formaldehyde can be released when chemicals in hair straighteners are heated, even if it's not listed as an ingredient. The FDA has considered banning it in hair care products.
  • Parabens: Used as preservatives, some parabens have been linked to hormone disruption and reproductive disorders.
  • Sodium hydroxide (lye): This caustic chemical, used in "lye relaxers," can cause severe burns. While many modern products are "no-lye," they often contain other strong alkalis that can still be harmful, especially when absorbed through an irritated scalp.

Key Scientific Studies and Findings

The scientific community has increasingly highlighted the dangers of hair relaxers. The turning point for the current lawsuit against hair relaxers was the October 2022 study from the National Institutes of Health (NIH).

  • NIH Sister Study (2022): This landmark study followed over 33,000 women for more than a decade. It found that women using hair straightening products more than four times a year were more than twice as likely to develop uterine cancer. The study estimated that 4.05% of frequent users would develop uterine cancer by age 70, compared to 1.64% of non-users. The lead author called this "doubling rate...concerning." You can read more from the National Institutes of Health (NIH).
  • Other Supporting Research: The NIH study reinforced earlier findings, including a 2019 study linking permanent hair straighteners to increased breast cancer risk and a 2021 study that further supported this link. A 2023 study of nearly 45,000 Black women also found that long-term relaxer use was associated with a significant increase in uterine cancer among menopausal women.

These studies provide the scientific backbone for the thousands of individuals pursuing legal action. For more information on the science, explore our page on Chemical Straightener Cancer.

The Growing Wave of Lawsuits Against Hair Relaxer Manufacturers

The scientific evidence has ignited a substantial legal movement, with thousands challenging cosmetic manufacturers. The lawsuit against hair relaxers is a significant mass tort seeking to hold companies accountable for allegedly failing to warn consumers about product dangers.

courthouse exterior - lawsuit against hair relaxers

Which Brands Are Named in the Lawsuits?

The lawsuit against hair relaxers targets a range of well-known manufacturers. Key brands and parent companies named in the litigation include:

  • L'Oréal: A central defendant through its SoftSheen-Carson brand, which makes Dark & Lovely and Optimum.
  • Revlon: A major player facing numerous lawsuits for products like Creme of Nature. Despite a bankruptcy filing, its insurance coverage may still allow for plaintiff recovery.
  • Namaste Laboratories: Known for its ORS Olive Oil Relaxer line.
  • Strength of Nature: The company behind popular brands like Motions and Just for Me, which was historically marketed to children.

While L'Oréal's French parent company was dismissed from the federal MDL on jurisdictional grounds, L'Oréal USA remains a key defendant. Other manufacturers involved include Avlon, Dermoviva, and John Paul Mitchell Systems.

Plaintiffs are suing under several legal theories, all centered on the manufacturers' failure to ensure product safety and inform consumers. The main grounds include:

  • Failure to Warn: The core claim that manufacturers knew or should have known about cancer risks but failed to provide adequate warnings on their products.
  • Negligence: An assertion that the companies were careless in the design, testing, manufacturing, or marketing of their hair relaxers.
  • Defective Design: The argument that the products were inherently dangerous due to their chemical composition, regardless of manufacturing quality.
  • Misrepresentation: Allegations that manufacturers falsely advertised their products as safe, misleading consumers.
  • Fraudulent Concealment: A claim that companies actively hid information about the dangers of their products from the public.

These arguments aim to show that companies prioritized profit over public health. Learn more in our comprehensive guide, Hair Relaxer Lawsuit.

Who Is Most Affected by These Health Risks?

The impact of these health risks is not evenly distributed. The lawsuit against hair relaxers highlights a significant demographic disparity, primarily affecting Black women and other women of color.

  • Disproportionate Use: Hair relaxers have been predominantly used by Black women, often starting at a young age and continuing for decades. Studies show about 60% of participants who reported using chemical straighteners were Black women, leading to higher cumulative exposure.
  • Targeted Marketing: For generations, cosmetic companies aggressively marketed relaxers to Black women and children, often leveraging societal pressures that favored straight hair.
  • Cultural Beauty Standards: Prominent attorneys have framed these cases as civil rights issues, arguing that Black women were pressured by marketing and societal beauty standards to use these products. The decision was not always purely aesthetic but a means of navigating a discriminatory society.

2026 Update: The Status of the Hair Relaxer MDL

For those following the lawsuit against hair relaxers, 2026 is a pivotal year. The litigation is progressing through key procedural milestones that are shaping its trajectory. We're here to keep you informed on the latest developments.

What is the Hair Relaxer MDL?

The thousands of individual lawsuits filed across the U.S. have been consolidated into a Multidistrict Litigation (MDL) to manage the cases more efficiently.

  • MDL 3060: Officially titled "Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation," this MDL was established in February 2023.
  • Northern District of Illinois: All federal hair relaxer lawsuits are managed by the U.S. District Court for the Northern District of Illinois.
  • Judge Mary Rowland: The litigation is overseen by Judge Mary M. Rowland, who manages all pretrial proceedings.
  • Efficiency in Litigation: The MDL streamlines findy and avoids conflicting rulings. As of early 2026, there were over 10,000 pending claims, and the number continues to grow.

This consolidation means that while each plaintiff retains their individual lawsuit, the pretrial process is handled collectively, paving the way for potential global settlements or bellwether trials.

The lawsuit against hair relaxers is moving steadily toward resolution:

  • Motions to Dismiss Denied: In a significant win for plaintiffs, Judge Rowland largely denied the manufacturers' motions to dismiss. This allows the majority of claims alleging negligence, defective design, and failure to warn to proceed.
  • Findy Phase: The litigation is deep in the findy phase, where both sides exchange evidence. This is a crucial period for uncovering internal company records about what manufacturers knew regarding product risks.
  • Bellwether Trials Underway: Perhaps the most significant development is the start of bellwether trials. The first of these test cases was held in late 2025, with more scheduled for 2026. Their outcomes are critical, as they can heavily influence settlement negotiations for the thousands of remaining claims.
  • "Science Day" Held: In early 2026, a "Science Day" was held to allow attorneys to educate Judge Rowland on the complex scientific evidence linking hair relaxers to cancer, setting the stage for trial arguments.
  • California's Toxic-Free Cosmetics Act: California has been proactive in regulating cosmetic ingredients, passing an act in 2020 that banned 24 chemicals, including some phthalates. This legislative action highlights growing awareness and could strengthen arguments in the litigation.

While no global settlements have been reached, these developments indicate a robust litigation process. For a deeper dive into how settlements work, visit our guide on Hair Relaxer Settlement and Payouts.

What Compensation Could Be Available in a Lawsuit Against Hair Relaxers?

If a lawsuit against hair relaxers is successful, harmed individuals could recover various types of compensation. While no settlements or verdicts have been announced in the MDL, potential damages include:

  • Medical Expenses: Past and future costs for diagnosis, treatment, surgeries, and ongoing care.
  • Lost Wages: Compensation for lost income and reduced earning capacity.
  • Pain and Suffering: For the physical pain and discomfort caused by the illness and treatments.
  • Emotional Distress: For the mental anguish, anxiety, and depression resulting from a diagnosis.
  • Loss of Quality of Life: For the impact on daily life, relationships, and overall well-being.
  • Punitive Damages: May be awarded if manufacturers are found to have acted with gross negligence, intended to punish the defendant.

It's important to reiterate that there are no settlements yet. However, legal experts speculate that average payouts for strong uterine cancer cases could range from $150,000 to $750,000 or more, depending on the severity of the injury and other factors. Cases involving younger plaintiffs with more severe outcomes could be valued even higher.

Frequently Asked Questions about Hair Relaxer Lawsuits

We understand that navigating a lawsuit against hair relaxers can be daunting. Here, we answer some common questions to help clarify the process.

Who is eligible to file a hair relaxer lawsuit?

To qualify for a lawsuit against hair relaxers, you generally need to meet the following criteria:

  • History of Regular Use: You must have regularly used chemical hair relaxer products for several years.
  • Specific Diagnosis: You must have been diagnosed with a condition linked to hair relaxers, such as:
    • Uterine cancer (including endometrial cancer)
    • Ovarian cancer
    • Uterine fibroids that required surgery (e.g., a hysterectomy).
  • Medical Documentation: You will need medical records to confirm your diagnosis and treatment.
  • Proof of Use: Evidence of the brands you used (receipts, packaging, photos, or testimony) will strengthen your claim.

Our team at Justice Hero offers a free case evaluation to help determine your eligibility.

What is the average payout for a hair relaxer lawsuit?

There is no average payout yet for a lawsuit against hair relaxers. The litigation is still progressing, with the first bellwether trials occurring in late 2025 and into 2026. No global settlements have been reached to establish a baseline for compensation.

Payouts will ultimately depend on several factors:

  • Injury Severity: More aggressive cancers or conditions leading to infertility will likely command higher compensation.
  • Age of the Plaintiff: Younger plaintiffs may receive higher awards for future suffering and loss of life enjoyment.
  • Economic Damages: Your past and future medical costs and lost wages are a key component.
  • Strength of Evidence: A clear, documented link between product use and your diagnosis is paramount.

While some legal experts speculate on potential settlement ranges ($150,000 to $750,000+ for strong cancer cases), these are currently estimates. The outcomes of the initial trials will provide a clearer picture of potential values.

What should I do if I believe I have a claim?

If you believe you have been harmed by chemical hair relaxers, take these steps to protect your legal rights:

  1. Preserve Evidence: Keep any old products, packaging, or receipts. Photos can also be helpful.
  2. Document Your History: Write down which brands you used, for how long, and how often.
  3. Gather Medical Records: Obtain all records related to your diagnosis, including pathology reports and bills.
  4. Consult with an Experienced Attorney: This is the most critical step. Contact a law firm experienced in mass torts. Our team at Justice Hero can connect you with qualified attorneys who will evaluate your case for free, explain your options, and ensure your claim is filed before any legal deadlines expire.

Holding Manufacturers Accountable

The ongoing litigation highlights a significant public health concern and a major legal battle against the cosmetic industry. Thousands of individuals, primarily Black women, are seeking justice, alleging that manufacturers failed to warn them of the severe cancer risks associated with chemical hair relaxers. As the MDL progresses, the focus remains on scientific evidence and holding companies accountable for the safety of their products. For those affected, understanding their legal rights is the first step toward seeking compensation. Justice Hero provides clear, reliable information to help you steer this complex process. If you believe you have been harmed, explore our comprehensive Hair Relaxer Lawsuit guide to learn more about your options.

On This Page

Case Status:

Defendants:

Injuries:

envelopephonemap-markercrossmenu